Guide for Authors
INTRODUCTION
Recognized for its authoritative contributions to the entire field of preventive medicine and public
health,
Preventive Medicine: An International Journal Devoted to Practice and Theory is a respected source of information on
applied research into all aspects of prevention.
Special Features include Original Research, Pertinent Issues and Innovation in:
•Cancer
•Cardiovascular disease
•Health education
•Individual and population risk factor screening
•Respiratory
and infectious disease
•Public health planning
•Tobacco and other substance abuse
•Stroke and hypertension
•Other lifestyle-related diseases
Special Issues Devoted to Specific Topics of Significance Have Included:
•Multiple
health behavior change research
•Self transportation, public transportation, and health
•Physiological and pharmacological
effects of Camellia sinensis
•Blood lipids in children: Optimal levels for early prevention of coronary artery disease
•Forum
on exercise and health
•Prevention of cardiovascular diseases
•Effectiveness and practice of patient education
•Health
promotion sciences: Their place in disease prevention
•Passive smoking
•Medical effects of nuclear war
•Fats
and fibers in carcinogenesis
•Coronary artery disease prevention: Cholesterol, a pediatric perspective
•Human cancer
chemoprevention
•Prevention cardiology
•Antiestrogen prevention of breast cancer
•MRFIT on cigarette smoking
Types of paper
Preventive Medicine is an international journal, publishing original, scholarly
manuscripts on all topics pertaining to preventive medicine, primary care, epidemiology, and public health, as well as methodology on
and historical aspects of all these topics. Article types (maximum number of words in main text) include Original Research (3500 words
for comparative intervention studies (e.g., randomized controlled trials), or 2500 words for studies not involving comparative interventions),
or shorter versions (1200 words, maximum of 2 tables and /or figures, 10 references maximum), Commentaries (800 words), Review Articles
(4000-4500 words), Book Reviews (1000-1500 words), and Letters to the Editor (500-1000 words, 10 references maximum). Word count ranges
do not include author citations within the text.
Manuscripts judged appropriate for the journal by the Editor-in-Chief and the Editor-Statistics
will receive an external review by peer reviewers, including at least one with expertise in statistical methods if deemed necessary.
Some manuscripts and their external reviews will also be evaluated by Associate Editors with expertise in the relevant discipline. The
final editorial decision rests with the Editor-in-Chief and the Editor-Statistics.
Contact
details for submission
Preventive Medicine manuscripts should be submitted using the journal's online submission
and review web site,
http://www.ees.elsevier.com/pm.
To use this submission route, please go to the web site and upload
your article and its associated artwork. A PDF is generated and the reviewing process is carried out using that PDF. All correspondence
between the Editors and the corresponding author is performed on this system. Paper copies are no longer required. However, please note
that source files will be required if your paper is accepted. If the manuscript cannot be submitted online, or for any questions regarding
submission, please contact:
Preventive Medicine Editorial Office
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Telephone:
(619) 699-6234
Fax: (619) 699-6859
E-mail:
pm@elsevier.com
Ethics in Publishing
For information on Ethics in Publishing and Ethical
guidelines for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest
including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted
work that could inappropriately influence, or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Preventive
Medicine requires full disclosure of all potential conflicts of interest. All authors of all types of journal articles are required
to indicate any financial interest in or arrangements with any company whose product was used in a study or is referred to in the article
or any other situations that may have potentially biased the work reported, its conclusions, implications, or opinion statements. These
include, for example, direct or indirect sources of funding for the individual author(s) or for the associated department(s) or organization(s),
personal relationships, or direct academic competition. If the manuscript is published, acknowledgment of all sources of funding and
financial involvements related to work must be made in the paper, and whether the project was initiated and analyzed by the investigator
or by the funding source must be divulged. At the end of the manuscript text (and in the cover letter of the manuscript), under a subheading
"Conflict of Interest statement", all authors must disclose any financial and personal relationships with other people or organisations
that could inappropriately influence (bias) their work. If there are no conflicts of interest, the authors should state, "The authors
declare that there are no conflicts of interest." Signed copies of the
Preventive Medicine Conflict of Interest policy form
are required upon submission. The Conflict of Interest policy form can be downloaded here (
http://www.elsevier.com/framework_products/promis_misc/COI_YPMED.doc).
In order to minimize delays, we strongly advise that the signed copies of these statements are prepared before you submit your manuscript.
The corresponding author is responsible for sharing this document with all co-authors. Each and every co-author must sign an individual
disclosure form. The corresponding author is responsible for uploading their form and those of their co-authors.
Submission declaration
Submission of an article implies that the work described has not been published previously
(except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without
the written consent of the copyright-holder.
Clinical trial results
In
line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the
same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the
form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors'
meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries
of results of the same or closely related work.
Reporting clinical trials
All
randomised controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT)
flow chart. Please refer to the CONSORT statement website at
http://www.consort-statement.org for more information. This
journal has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which require, as a condition of
consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset
of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. For this purpose,
a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related
interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical
or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care
changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic
measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion
of the investigator) will not require registration. Further information can be found at
http://www.icmje.org.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such
involvement then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors
whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
US National Institutes of Health (NIH) voluntary posting ("Public Access") policy. Elsevier facilitates author response to the NIH
voluntary posting request (referred to as the NIH "Public Access Policy"; see
http://publicaccess.nih.gov/) by posting
the author's peerreviewed manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon
notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at
NIHauthorrequest@ elsevier.com)
that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to
facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that
will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully
to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is
prohibited.
Language and language services
Please write your text in good
English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and
copyediting services pre- and post-submission please visit
http://www.elsevier.com/languagepolishing or our customer support
site at
http://epsupport.elsevier.com for more information. Please note Elsevier neither endorses nor takes responsibility
for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please
refer to our Terms & Conditions:
http://www.elsevier.com/termsandconditions.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and
uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review
process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these
source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision
and requests for revision, takes place by e-mail removing the need for a paper trail.
Use of wordprocessing software
It is important
that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of
the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use
the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc.
Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables,
if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs,
not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also
the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication). Do not import the figures into the text
file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on
Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions
of your wordprocessor.
LaTeX
If the LaTeX file is suitable, proofs will
be produced without rekeying the text. The article should preferably be written using Elsevier's document class "elsarticle", or alternatively
the standard document class "article".
The Elsevier LaTeX style file package (including detailed instructions for LaTeX preparation)
can be obtained from the Quickguide:
http://www.elsevier.com/latex. It consists of the file: elsarticle.cls, complete user
documentation for the class file, bibliographic style files in various styles, and template files for a quick start.
Article structure
Please include appropriate Cover Letter (with CONSORT checklist is appropriate).
The Title Page should include the usual - title, authors' names and affiliations, the corresponding author's name and e-mail address
- as well as the word counts of the main text and abstract (word count excludes in-text citations and references). Text should be 1.5
line-spaced. Do not use footnotes in the text.
Subdivision - numbered sections
Main headings are
Introduction,
Methods,
Results,
Discussion, and
Conclusion.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed
literature survey or a summary of the results.
Materials and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only
relevant modifications should be described. The
Methods section should include a separate, second-level subsection,
Statistical
analyses (if applicable), which concisely describes the statistical methodology.
Experimental
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated
by a reference: only relevant modifications should be described.
Theory/calculation
A Theory section should extend, not repeat, the background to the article already dealt with in the Introduction and lay the foundation
for further work. In contrast, a Calculation section represents a practical development from a theoretical basis.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined
Results and Discussion section
is often appropriate. Avoid extensive citations and discussion of published literature. In this section, a second-level subsection entitled
Study limitations and strengths is strongly encouraged.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of
a Discussion or Results and Discussion section.
Appendices
If there
is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering:
Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on.
Essential
title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval
systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name
may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in
front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available,
the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at
all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code)
are provided in addition to the e-mail address and the complete postal address.
•
Present/permanent address.
If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent
address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained
as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A structured abstract, 200 words or less, comprising
Objective,
Method,
Results,
Conclusion.
Abstracts should include sample sizes and the location and date of the study.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations
that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of
abbreviations throughout the article.
Acknowledgements
Collate acknowledgements
in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote
to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing
assistance or proof reading the article, etc.).
Math formulae
Present
simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms,
e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively
any equations that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript
Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate
the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes
in the Reference list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing
of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following
fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
•
Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide
on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged
to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application
used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save
the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line
drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please
do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that
are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color
artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct
resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge,
that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version.
For color reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For
further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please
note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should
you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached
to the figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Text graphics
Present incidental graphics not suitable for mention as figures, plates or schemes at the end of the
article and number them "Graphic 1", etc. Their precise position in the text can then be indicated. See further under Electronic artwork.
If you are working with LaTeX and have such features embedded in the text, these can be left, but such embedding should not be done specifically
for publishing purposes. Further, high-resolution graphics files must be provided separately.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below
the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure
that the data presented in tables do not duplicate results described elsewhere in the article.
Tables should be short, single-spaced
and begin on a separate page. Table legends should provide details on the location and date of the study, and the study population (if
applicable). The aim of presenting tables results is not only to show adjusted effects but also to enable readers to understand the methods
used, evaluate the results, and potentially integrate them into meta-analyses. Thus, presentation of sufficient detail in tables to permit
readers to compute crude (unadjusted) effects is strongly encouraged. (For example, adjusted odds ratios should also be accompanied by
subgroup sample sizes or percentages for each variable included in the model.)
References
Citation in text
Please ensure that every reference cited in the
text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished
results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references
are included in the reference list they should follow the standard reference style of the journal and should include a substitution of
the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that
the item has been accepted for publication.
Web references
As a minimum,
the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired,
or can be included in the reference list.
Reference to arXiv
As with
unpublished results and personal communications, references to arXiv documents are not recommended in the reference list. Please make
every effort to obtain the full reference of the published version of an arXiv document. If a reference to an arXiv document must be
included in the references list it should follow the standard reference style of the journal and should include a substitution of the
volume and page numbers with 'arXiv:YYMM.NNNN' or 'arXiv:arch-ive/YYMMNNN' for papers submitted to arXiv before April 2007.
References in a special issue
Please ensure that the words 'this issue' are added to any references
in the list (and any citations in the text) to other articles in the same Special Issue.
Reference style
Text: All citations in the text should refer to:
1.
Single author: the author's
name (without initials, unless there is ambiguity) and the year of publication;
2.
Two authors: both authors' names and
the year of publication;
3.
Three or more authors: first author's name followed by "et al." and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown ...."
List:
References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from
the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific article.
J. Sci. Commun. 163, 51-59.
Reference to a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan,
New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of
your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal
abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Supplementary
material
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary
files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images,
background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your
submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit
the material in electronic format together with the article and supply a concise and descriptive caption for each file. Video files:
please supply 'stills' with your files: you can choose any frame from the video or make a separate image. These will be used instead
of standard icons and will personalize the link to your supplementary information. For more detailed instructions please visit our artwork
instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission
checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's
Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are
present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone
and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including
title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
•
References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text,
and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
•
Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced
in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white
versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site
at
http://epsupport.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to
electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon
the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly
'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown
as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When
you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how
to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and
return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then
mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the
text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of
your article if no response is received.
Offprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional paper
offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.
For inquiries relating to the submission of articles (including electronic submission
where available) please visit this journal's homepage. You can track accepted articles at
http://www.elsevier.com/trackarticle
and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright,
frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating
to proofs, will be provided by the publisher.
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company